Twenty-six (41.9%) and 24 (66.7%) patients underwent CT for ILRR in the ER-positive/PR-negative/HRE2-negative and ER-negative/PR-negative/HER2-negative tumor groups, respectively. The gene discussed is ESR1; the disease is neoplasm.